BCHE and Alzheimer disease: The disease is characterized by low levels of the neurotransmitter acetylcholine (ACh) in the brain and, therefore, a possible treatment of AD is associated with increasing the amount of ACh in the cholinergic synapses by inhibiting the two types of cholinesterase enzymes (acetylcholinesterase AChE and butyrylcholinesterase BChE).